Living meta-analysis and evidence synthesis of therapies for COVID-19

 

• COVID 19 hospitalized
• COVID 19 all comers
• COVID-19 mild to moderate
• COVID-19 severe or critically
• COVID 19 outpatients
• COVID-19 (hospitalized or not)
• COVID-19 prophylaxis (children)
• COVID-19 prophylaxis (excluding children)
• infections other than COVID-19
• Long COVID-19
• preventing respiratory virus transmission
• secondary prevention

 

• adjuvant therapies
• anticoagulant
• anticoagulant, curative dose
• anticoagulant, pre-admission
• anticoagulant, prophylactic dose
• sulodexide
• face mask
• anti-inflammatoty and immuno-therapy
• anti-inflammatory therapies
• colchicine
• non-steroidal anti-inflammatory drugs
• Ibuprofen
• corticosteroids
• Immunostimulants drugs
• convalescent plasma treatment
• interferon
• IFN beta-1a
• levamisole
• neutralizing antibody
• casirivimab/imdevimab (Ronapreve)
• Immunosuppressants drugs
• anti-interleukin-6
• tocilizumab
• statins
• antiandrogenic
• 5-alpha-reductase inhibitors
• antiviral and associated therapy
• azithromycin
• bromhexine
• chloroquine and derivatives
• chloroquine
• hydroxychloroquine
• doxycycline
• favipiravir
• fluvoxamine
• hydroxychloroquine plus macrolides
• ivermectin
• lopinavir/ritonavir
• zinc
• Drugs for acid related disorders
• proton pump inhibitors (PPI)
• miscellaneous
• 2-deoxy-D-glucose (2-DG)
• acetylcysteine
• calcium channel blocker
• kinin-kallikrein inhibitors
• nicotin
• ozonated autohemotherapy
• radiotherapy
• Oral antidiabetic drugs
• DPP-4 inhibitor
• metformin
• Renin-angiotensin-system-acting agents
• angiotensin converting enzyme inhibitors (ACEIs)
• angiotensin receptor blockers (ARBs)
• vaccines
• BCG vaccination
• DNA vaccine
• bacTRL-Spike
• Vitamins
• vitamin C
• All treatment (not recommended)

    Top evidence (RCT only, high risk of bias excluded) Best available evidence (possibly low or very low) All RCTs All studies (RCT+OBS) see more...